April 2021 vol 27 no 3

Type 2 diabetes: Two new medications offer fresh management paradigm

April 1, 2021

Current international guidelines for type 2 diabetes management include the use of two new classes of medication: sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, in people with established kidney disease, heart disease or heart failure, or with high cardiovascular risk.1

Read more... Type 2 diabetes: Two new medications offer fresh management paradigm

November 2020 vol 26 no 10

Talking about health: Experiences with the general practice team and support for self-management

November 1, 2020

The fifth and final of a series of professional education articles based on the Talking about Health study looks at the relationships between people with long-term conditions and general practice nurses and doctors.

Read more... Talking about health: Experiences with the general practice team and support for self-management